Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Mots-C

Mitochondrial open reading frame of the 12S rRNA-c, MT-RNR1, Mitochondrial-derived peptide MOTS-c

Quick Stats
Studies 137
Trials 5
Score 2
2023 pubmed 4 citations

Β-GPA administration activates slow oxidative muscle signaling pathways and protects soleus muscle against the increased fatigue under 7-days of rat hindlimb suspension.

Sharlo. K A KA; Lvova. I D ID; Sidorenko. D A DA; Tyganov. S A SA; Sharlo. D T DT; Shenkman. B S BS

Key Findings

  • β‑GPA (400 mg/kg) protected slow‑twitch signaling pathways (MOTS‑C, AMPK, PGC‑1α, miR‑499) during 7‑day hindlimb unloading
  • Treated rats maintained soleus fatigue resistance, slow‑type fiber proportion, and mitochondrial DNA copy number
  • β‑GPA acts as a creatine‑kinase inhibitor, reducing ATP and phosphocreatine levels

Practical Outcomes

  • The study suggests β‑GPA might help prevent muscle loss during periods of inactivity, but the high animal dose and lack of human data limit direct use. Biohackers should view this as early‑stage evidence and await safety and dosing research before considering any protocol.

Summary

In rats, giving the compound β‑GPA while their hindlimbs were unloaded helped keep the slow‑twitch soleus muscle from getting weaker and more fatigued, preserving its fiber type and mitochondrial content. The drug works by lowering ATP and phosphocreatine, which surprisingly kept key muscle‑maintenance signals active.

Abstract

Unloading of slow-twitch muscles results in increased muscle fatigue and the mechanisms of this effect are poorly studied. We aimed to analyze the role of high-energy phosphates accumulation during the first week of rat hindlimb suspension plays in a fiber-type phenotype shift towards fast-type fatigable muscle fibers. Male Wistar rats were divided into 3 groups (n = 8): C - vivarium control; 7HS - 7-day hindlimb suspension; 7HB - 7-day hindlimb suspension with intraperitoneal injection of beta-guanidine propionic acid (β-GPA, 400 mg/kg b w). β-GPA is a competitive inhibitor of creatine kinase and it reduces concentrations of ATP and phosphocreatine. In the 7HB group, β-GPA treatment protected a slow-type signaling network in an unloaded soleus muscle, including MOTS-C, AMPK, PGC1 α and micro-RNA-499. These signaling effects resulted in a preserved soleus muscle fatigue resistance, slow-type muscle fibers percentage and mitochondrial DNA copy number under muscle unloading.

Study Information

Provider

pubmed

Year

2023

Date

2023-05-24T00:00:00.000Z

DOI

10.1016/j.abb.2023.109647

Citations

4

References

45